These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1002821

  • 1. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G, Masala A, Alagna S, Devilla L, Lotti G.
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
    Chiodini PG, Liuzzi A, Muller EE, Botalla L, Cremascoli G, Oppizzi G, Verde G, Silvestrini F.
    J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
    [Abstract] [Full Text] [Related]

  • 3. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Delitala G.
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
    [Abstract] [Full Text] [Related]

  • 4. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
    Agnati LF, Benfenati F, Frank G, Capelli M, Bernardi P, Calza L.
    Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088
    [Abstract] [Full Text] [Related]

  • 5. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Pontiroli AE, Castegnaro E, Vettaro MP, Viberti GC, Pozza G.
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
    [No Abstract] [Full Text] [Related]

  • 6. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 7. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa.
    Pontiroli AE, Viberti GC, Tognetti A, Pozza G.
    Horm Metab Res; 1976 Mar; 8(2):106-8. PubMed ID: 1261961
    [Abstract] [Full Text] [Related]

  • 8. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I, Kataoka K, Tomita A, Takanohashi M, Nakane T, Kuwayama A, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan 20; 55(1):16-24. PubMed ID: 581754
    [Abstract] [Full Text] [Related]

  • 9. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ.
    J Clin Endocrinol Metab; 1985 Jun 20; 60(6):1148-53. PubMed ID: 3923021
    [Abstract] [Full Text] [Related]

  • 10. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan 20; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 11. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG, Kato K, De Moll H.
    Obstet Gynecol; 1988 Jan 20; 71(1):53-5. PubMed ID: 3336541
    [Abstract] [Full Text] [Related]

  • 12. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
    Ishibashi M, Yamaji T, Kosaka K.
    J Clin Endocrinol Metab; 1978 Aug 20; 47(2):418-21. PubMed ID: 400720
    [Abstract] [Full Text] [Related]

  • 13. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L, McCann SM, Mayfield MA.
    Endocrinology; 1981 Apr 20; 108(4):1115-24. PubMed ID: 7472261
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K, Sasaki A, Sato S, Goh M, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb 20; 64(2):255-60. PubMed ID: 3793848
    [Abstract] [Full Text] [Related]

  • 15. Action of metergoline in suppressing prolactin release induced by mechanical breast emptying.
    Delitala G, Lodico G, Masala A, Alagna S, Devilla L.
    J Clin Endocrinol Metab; 1977 Apr 20; 44(4):763-5. PubMed ID: 849985
    [Abstract] [Full Text] [Related]

  • 16. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
    Felt V, Nedvídková J, Krejcík L, Hainer V.
    Cas Lek Cesk; 1977 May 13; 116(19):591-4. PubMed ID: 406999
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of prolactin release by metergoline administration in man.
    Delitala G, Masala A, Alagna S, Devilla L, Rovasio PP.
    Biomedicine; 1977 Jan 31; 27(1):31-3. PubMed ID: 856312
    [Abstract] [Full Text] [Related]

  • 18. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1978 Dec 31; 47(6):1251-6. PubMed ID: 122426
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
    Ferrari C, Caldara R, Rampini P, Telloli P, Romussi M, Bertazzoni A, Polloni G, Mattei A, Crosignani PG.
    Metabolism; 1978 Oct 31; 27(10):1499-504. PubMed ID: 692379
    [Abstract] [Full Text] [Related]

  • 20. Regulation of prolactin and growth hormone secretion. Site and mechanism of action of thyrotropin-releasing hormone, L-dopa and L-5-hydroxytryptophan in unanesthetized dogs.
    Richards GE, Holland FJ, Aubert ML, Ganong WF, Kaplan SL, Grumbach MM.
    Neuroendocrinology; 1980 Oct 31; 30(3):139-43. PubMed ID: 6767993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.